Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime
| Autor: | Warren D. Johnson, P.D. Marsden, Jackson Mauricio Lopes Costa, C.C. Cuba, Roberto Badaró, E. A. Llanos-Cuentas, A.C. Barreto, Thomas C. Jones, Eduardo Martins Netto |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Adult
Antimony Male medicine.medical_specialty Time Factors Adolescent Meglumine antimoniate Mucocutaneous zone Antiprotozoal Agents Gastroenterology Leishmania braziliensis Serology Pharmacotherapy Meglumine Recurrence Internal medicine Skin Ulcer medicine Organometallic Compounds Animals Humans Child Leishmaniasis Aged Meglumine Antimoniate biology business.industry Public Health Environmental and Occupational Health General Medicine Skin ulcer biology.organism_classification Leishmania medicine.disease Infectious Diseases Immunology Parasitology Female medicine.symptom business medicine.drug |
| Zdroj: | Transactions of the Royal Society of Tropical Medicine and Hygiene. 84(3) |
| ISSN: | 0035-9203 |
| Popis: | Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Tres Bracos, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6/62 (10%), mucosal relapse after cutaneous infection in 2/62 (3%), and mucosal relapse after mucosal disease in 2/17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|